RxDoctor Payments Data

Sean Oser, MD

Family Medicine · Aurora, CONPI 1720083140

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Dexcom, Inc. at 35.1% of the total. Reporting peaked in 2019 at $6,374 and has fallen 97.3% since, to $174 in 2025. Among family medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,497in general payments, 2019–2025

Across 49 payments — averaging $459.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$8K
  • Bayer$7K
  • Ascensia Diabetes Care US Inc.$5K
  • Insulet Corporation$919
  • BETA Bionics, Inc.$778
  • Abbott$574
  • plus $279 from 2 others
$225,320in research payments, 2019–2025

Across 16 payments — averaging $14,083 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dexcom, Inc.$225K

What the payments were for

  • Consulting fees$9,07040%
  • Speaking & faculty fees$6,36928%
  • Travel & lodging$4,18219%
  • Food & beverage$2,67712%
  • Education$2001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,497 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$8,642
Medicare patients
54
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin31$39,398
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$4,737
SynthroidLevothyroxine Sodium23$1,333
Atorvastatin Calcium47$724
Rosuvastatin Calcium50$618
Pantoprazole Sodium25$504
Omeprazole27$415
Levothyroxine Sodium41$323
Morphine Sulfate ErMorphine Sulfate12$308
Pregabalin13$277
Amlodipine Besylate17$265
Lisinopril28$250
Sertraline Hcl13$245
Allopurinol15$242
Metformin Hcl18$226

Paid to pharmacies, not to this prescriber.

Other family medicine in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →